Measured Risk Portfolios’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Measured Risk Portfolios's LLY Position: Q2 2026 in Review
Measured Risk Portfolios reduced its Eli Lilly (LLY) stake by 12% in Q2 2026, selling an estimated $27.6K and leaving 196 shares worth $235K. The position accounts for 0.21% of the portfolio, ranked #59.
Measured Risk Portfolios first reported a position in LLY in Q4 2024 and has held it in 4 quarters since. The position peaked at $240K in Q4 2025. 4,642 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Measured Risk Portfolios held 196 shares of Eli Lilly worth $235K as of Q2 2026.
- Measured Risk Portfolios sold 27 Eli Lilly shares in Q2 2026, an estimated $27.6K.
- Eli Lilly made up 0.21% of Measured Risk Portfolios's portfolio in Q2 2026, its #59 holding.
- Measured Risk Portfolios first reported a position in Eli Lilly in Q4 2024 and has held it in 4 quarters since.
- Measured Risk Portfolios's Eli Lilly position peaked at $240K in Q4 2025.
- 4,642 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Measured Risk Portfolios's 13F filing for Q2 2026, filed 12 Aug 2026.